ScreenerHero
IMMNOVImmunovia AB
STO · SE · Healthcare · Diagnostics & Research · immunovia.com
0.1556SEK-1.52%Mkt Cap: 10.17M $P/E: —

Immunovia AB (publ), a diagnostic company, develops and validates blood test for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins a…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group Ltd
$46.70BUSDP/E 37.9
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.64BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMerieux S.A.
$9.51BUSDP/E 19.0
QIA
Qiagen N.V.
$8.69BUSDP/E 22.8
TWST
Twist Bioscience Corp.
$8.93BUSD

Key Statistics

Company
Market Cap10.17M $
Enterprise Value7.14M $
Revenue (TTM)115.83K $
Gross Profit52.51K $
Net Income (TTM)-13.96M $
Revenue/Share0.0002 USD
Last Price0.1556 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees18
CountrySE
SectorHealthcare
IndustryDiagnostics & Research
ISINSE0006091997
Valuation
P/E (Trailing)—
P/E (Forward)0.02
PEG—
EV/EBITDA-0.90
EV/Revenue61.65
P/S86.43
P/B4.45
EPS (TTM)-0.08
EPS (Forward)7.00
52W Range
0.15001% of range0.7527
52W High0.7527 SEK
52W Low0.1500 SEK
Profitability
Gross Margin80.15%
Oper. Margin-6011.29%
EBITDA Margin0.00%
Profit Margin-21301.46%
ROE-225.30%
ROA-165.41%
Growth
Revenue Growth323.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.50M $
CapEx (TTM)531.73K $
FCF Margin-3327.10%
FCF Yield-37.91%
Net Debt-3.03M $
Net Debt/EBITDA0.38
Balance Sheet
Debt/Equity0.01
Current Ratio1.57
Quick Ratio1.55
Book Value/Sh0.0350 SEK
Cash/Share0.0520 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateFeb 3, 2026
Analyst Consensus
Rating0.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)0.4300 SEK
Upside (mean)+176.3%
Target Range0.4300 SEK – 0.4300 SEK
# Analysts1
Ownership
Shares Out.672.67M
Float610.39M
Insiders9.77%
Institutions16.98%
Technical
SMA 500.1838 (-15.3%)
SMA 2000.2045 (-23.9%)
Beta2.65
S&P 52W Chg18.16%
Avg Vol (30d)2.11M
Avg Vol (10d)3.06M
Technical Indicators
RSI (14)32.6
MACD-0.0083
MACD Signal-0.0071
MACD Hist.-0.0012
BB Upper0.1910 SEK
BB Middle0.1705 SEK
BB Lower0.1500 SEK
BB Width24.07%
ATR (14)0.0093 SEK
Vol Ratio (20d)0.65x